Marine cone snails have developed many distinct venoms that contain biologi
cally active peptides as part of an envenomation survival strategy for feed
ing and defense. These peptides, known as conopeptides, have been optimized
through evolution to target specific ion channels and receptors with very
high affinities and selectivities. Side effects of currently available ther
apies often arise from their lack of selectivity between pharmacologically
relevant. targets and targets that have a similar structure but different f
unction. As conopeptides can be highly selective between closely related re
ceptor subtypes, they could meet specific therapeutic needs with a reduced
likelihood of side effects.